Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice

Inherited hematologic defects that lack an in vivo selective advantage following gene correction may benefit from effective yet minimally toxic cytoreduction of endogenous hematopoietic stem cells (HSCs) prior to transplantation of gene-modified HSCs. We studied the efficacy of administering a novel...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Xue, Xingkui, Pech, Nancy K., Shelley, W. Christopher, Srour, Edward F., Yoder, Mervin C., Dinauer, Mary C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2010
Konular:
Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012550/
https://ncbi.nlm.nih.gov/pubmed/20813896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-295949
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller